The same principles could be applied to the refractory nature of PTEN-deficient PCa to ICB, though an alternative explanation may be the ‘immune desert’ phenotype recapitulated, for example, by PtenPC−/−; PmlPC−/− tumours (Bezzi et al. 2018). This evidence concerns the gene PTEN and neoplasm.